Federal watchdog would study remote monitoring for patients prescribed opioids

The Comptroller General, who leads Congress’s watchdog agency, would study remote monitoring and report to congressional committees. The study would cover people prescribed opioids. The report would assess scientific evidence, patient outcomes, possible savings, and current use, including abroad. It would recommend ways to improve access and coverage, including through federal health programs. The agency could identify groups most likely to benefit if it finds that appropriate. The study and report would be completed within 18 months after enactment.